https://neurosciencenews.com/sleep-apnea-neuropharmacology-21585ea/
0
0
10/6/22 at 6:50pm
Organization
Neurosciencenews.com
Author
Neuroscience News
23 words
0
Comments
Reboxetine, a selective norepinephrine reuptake inhibitor normally prescribed for depression, can reduce sleep apnea symptom severity.
You are the first to view
Create an account
or login to join the discussion